152 related articles for article (PubMed ID: 36601689)
21.
Wu HT; Wu Z; Hou YY; Fang ZX; Wu BX; Deng Y; Cui YK; Liu J
Epigenomics; 2023 Sep; 15(18):911-925. PubMed ID: 37905439
[No Abstract] [Full Text] [Related]
22. SIX4 promotes metastasis through STAT3 activation in breast cancer.
Sun X; Ma J; Chen Q; Hou Z; Luo X; Wang G; Wang J; Hu J; Cao Z
Am J Cancer Res; 2020; 10(1):224-236. PubMed ID: 32064163
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer.
Himeda CL; Ranish JA; Angello JC; Maire P; Aebersold R; Hauschka SD
Mol Cell Biol; 2004 Mar; 24(5):2132-43. PubMed ID: 14966291
[TBL] [Abstract][Full Text] [Related]
24. Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin.
Vazirabad AF; Noorolyai S; Baghbani E; Mahboob S; Zargari F; Rahmani S; Sorkhabi A; Montazami N; Sameti P; Baradaran B
Pathol Res Pract; 2022 Dec; 240():154194. PubMed ID: 36370483
[TBL] [Abstract][Full Text] [Related]
25. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
26. Expression of three zebrafish Six4 genes in the cranial sensory placodes and the developing somites.
Kobayashi M; Osanai H; Kawakami K; Yamamoto M
Mech Dev; 2000 Nov; 98(1-2):151-5. PubMed ID: 11044620
[TBL] [Abstract][Full Text] [Related]
27. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
[TBL] [Abstract][Full Text] [Related]
28. SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.
Li G; Hu F; Luo X; Hu J; Feng Y
PeerJ; 2017; 5():e3394. PubMed ID: 28584719
[TBL] [Abstract][Full Text] [Related]
29. Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.
Kerr DA; Lopez HU; Deshpande V; Hornicek FJ; Duan Z; Zhang Y; Rosenberg AE; Borger DR; Nielsen GP
Am J Surg Pathol; 2013 Jun; 37(6):787-95. PubMed ID: 23598960
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association between Six4, MyoD, and the histone demethylase Utx during myogenesis.
Chakroun I; Yang D; Girgis J; Gunasekharan A; Phenix H; Kærn M; Blais A
FASEB J; 2015 Nov; 29(11):4738-55. PubMed ID: 26229056
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism in promoter of SIX4 gene shows association with its transcription and body measurement traits in Qinchuan cattle.
Wei D; Raza SHA; Zhang J; Gui L; Rahman SU; Khan R; Hosseini SM; Kaleri HA; Zan L
Gene; 2018 May; 656():9-16. PubMed ID: 29496553
[TBL] [Abstract][Full Text] [Related]
32. Development of gustatory papillae in the absence of Six1 and Six4.
Suzuki Y; Ikeda K; Kawakami K
J Anat; 2011 Dec; 219(6):710-21. PubMed ID: 21978088
[TBL] [Abstract][Full Text] [Related]
33. Structure and chromosome mapping of the human SIX4 and murine Six4 genes.
Ozaki H; Yamada K; Kobayashi M; Asakawa S; Minoshima S; Shimizu N; Kajitani M; Kawakami K
Cytogenet Cell Genet; 1999; 87(1-2):108-12. PubMed ID: 10640827
[TBL] [Abstract][Full Text] [Related]
34. Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1.
Liu X; Kato Y; Kaneko MK; Sugawara M; Ogasawara S; Tsujimoto Y; Naganuma Y; Yamakawa M; Tsuchiya T; Takagi M
Cancer Med; 2013 Dec; 2(6):803-14. PubMed ID: 24403254
[TBL] [Abstract][Full Text] [Related]
35. Six1 and Six4 are essential for Gdnf expression in the metanephric mesenchyme and ureteric bud formation, while Six1 deficiency alone causes mesonephric-tubule defects.
Kobayashi H; Kawakami K; Asashima M; Nishinakamura R
Mech Dev; 2007 Apr; 124(4):290-303. PubMed ID: 17300925
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.
Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
[TBL] [Abstract][Full Text] [Related]
37. Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT).
Grassian AR; Lin F; Barrett R; Liu Y; Jiang W; Korpal M; Astley H; Gitterman D; Henley T; Howes R; Levell J; Korn JM; Pagliarini R
J Biol Chem; 2012 Dec; 287(50):42180-94. PubMed ID: 23038259
[TBL] [Abstract][Full Text] [Related]
38. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
[TBL] [Abstract][Full Text] [Related]
39. Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.
Liu WS; Chan SH; Chang HT; Li GC; Tu YT; Tseng HH; Fu TY; Chang HY; Liou HH; Ger LP; Tsai KW
Breast Cancer Res; 2018 Apr; 20(1):25. PubMed ID: 29661250
[TBL] [Abstract][Full Text] [Related]
40. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya.
Ohto H; Kamada S; Tago K; Tominaga SI; Ozaki H; Sato S; Kawakami K
Mol Cell Biol; 1999 Oct; 19(10):6815-24. PubMed ID: 10490620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
